SCHEMBL30121740

SCHEMBL30121740

Nc1nc(Nc2ccc(N3CCC(N4CCCC4)CC3)c(F)c2)nn1-c1cc2c(nn1)-c1ccccc1OCC2

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 13/20 0.82
KDR P35968 4/20 0.61
KIT P10721 3/20 0.61
FLT3 P36888 3/20 0.61
EGFR P00533 3/20 0.61
MET P08581 2/20 0.61
SRC P12931 2/20 0.61
AURKA O14965 1/20 0.61
RET P07949 1/20 0.61
PDGFRA P16234 1/20 0.61
TYRO3 Q06418 1/20 0.61
DDR1 Q08345 1/20 0.61
MERTK Q12866 1/20 0.61
AURKB Q96GD4 1/20 0.61
ALK Q9UM73 1/20 0.61
INSR P06213 1/20 0.43
CSF1R P07333 1/20 0.42
CDK4 P11802 1/20 0.42
CDK6 Q00534 1/20 0.42
ABL1 P00519 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL468042 1.00 AXL (0.82) AXLKDRKITFLT3EGFR
SCHEMBL1640412 0.90 AXL (0.65) AXLKDRKITFLT3EGFR
SCHEMBL4986435 0.90 AXL (1.00) AXLKDRKITFLT3EGFR
SCHEMBL30090872 0.89 AXL (0.96) AXLKDRKITFLT3EGFR
SCHEMBL1639248 0.89 AXL (0.96) AXLKDRKITFLT3EGFR
SCHEMBL1640216 0.89 AXL (0.94) AXLKDRKITFLT3EGFR
SCHEMBL30121598 0.88 AXL (0.82) AXLKDRKITFLT3EGFR
SCHEMBL1639243 0.88 AXL (0.82) AXLKDRKITFLT3EGFR
SCHEMBL1640251 0.87 AXL (0.92) AXLKDRKITFLT3EGFR
SCHEMBL30090792 0.87 AXL (0.92) AXLKDRKITFLT3EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4138823-A1 METHOD OF SELECTING PATIENTS FOR TREATMENT WITH A COMBINATION OF AN AXL INHIBITOR AND AN IMMUNE CHECKPOINT MODULATOR BerGenBio ASA (NO) 2023-03-01 EP disclosed
EP-4132652-A1 AXL INHIBITORS FOR ANTIVIRAL THERAPY BerGenBio ASA (NO) 2023-02-15 EP disclosed
EP-4125908-A1 COMBINATION THERAPY COMPRISING AN AXL INHIBITOR BerGenBio ASA (NO) 2023-02-08 EP disclosed